Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

CMS proposes narrowly covering controversial Alzheimer’s drug Aduhelm for patients in clinical trials,

CMS is proposing to have Medicare cover controversial Alzheimer’s disease drug Aduhelm, but only for patients in qualifying clinical trials., CMS is proposing to have Medicare cover controversial Alzheimer’s disease drug Aduhelm, but only for patients in qualifying clinical trials., Read More

Scroll to Top